What's new

PSUSA/00010072/202409

PSUSA/00010072/202409

May 12, 2025 - 14:39
 0
PSUSA/00010072/202409
PSUSA/00010072/202409
Read More

Tags:

Previous Article

STAT+: FDA approves Verastem’s ovarian cancer treatment

Next Article

US and UK Trade Deal – Key Provisions and Supply Chain Implications

Related Posts

PSUSA/00002643/202408

PSUSA/00002643/202408

May 12, 2025  0

Human medicines European public assessment report (EPAR): Givlaari, givosiran, Date of authorisation: 02/03/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

May 8, 2025  0

Agenda of the PRAC meeting 5-8 May 2025

May 6, 2025  0